Autoimmune diseases: Role of steroid hormones.


Journal

Best practice & research. Clinical obstetrics & gynaecology
ISSN: 1532-1932
Titre abrégé: Best Pract Res Clin Obstet Gynaecol
Pays: Netherlands
ID NLM: 101121582

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 23 01 2019
accepted: 01 03 2019
pubmed: 3 5 2019
medline: 18 2 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

Autoimmune diseases (AIDs) are a heterogeneous group of disorders in terms of clinical manifestations, pathogenesis, and prevalence, and there is no agreement to date on a common classification. Adaptive immune responses are responsible for the existence of AIDs, although innate immunity is also involved in misguiding the immune response against self-antigens. Hormones, in general, and in particular steroid hormones, play a critical role in the physiology and pathology of the immune system, especially in adaptive immunity. Hormonal factors, alone or in relation to age, sex, and reproductive status, are involved in conditioning the onset of a number of AIDs. There is a well-defined sexual dimorphism for human AIDs. At the same time, the classic view has been that steroid hormones have well-defined effects, with one type, estrogens, being "pro-inflammatory" and the other two progestogens (progesterone and its synthetic analogs) and androgens being "anti-inflammatory." Although this view has been considered too simplistic and seems contradicted by numerous observations, it remains valid: progestogens and androgens are immunosuppressive and therefore protective against AIDs, whereas estrogens are immune-stimulatory and therefore pathogenic in AIDs.

Identifiants

pubmed: 31047850
pii: S1521-6934(19)30023-9
doi: 10.1016/j.bpobgyn.2019.03.001
pii:
doi:

Substances chimiques

Androgens 0
Estrogens 0
Progesterone 4G7DS2Q64Y

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-34

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Marisa Benagiano (M)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Paola Bianchi (P)

Department of Medico-Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza, University of Rome, Rome, Italy. Electronic address: paola.bianchi@uniroma1.it.

Mario Milco D'Elios (MM)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Ivo Brosens (I)

Faculty of Medicine, Catholic University of Leuven, Leuven, Belgium.

Giuseppe Benagiano (G)

Department of Obstetrics, Gynaecology and Urology, Policlinico Umberto I, Sapienza, University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH